{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/13/3344397/0/en/mink-therapeutics-reports-second-quarter-2026-financial-results-and-reports-observations-from-randomized-phase-2-trial-of-agent-797-in-acute-lung-injury.html", "message": "News view counter 880652 successfully enlarged"}